BiondiB, GalderisiM, PaganoL, SidiropulosM, PulcranoM, D'ErricoA, IppolitoS, RossiA, de DivitiisO, LombardiG. 2009. Endothelial-mediated coronary flow reserve in patients with mild thyroid hormone deficiency. Eur J Endocrinol, 161:323–329.
2.
DardanoA, MonzaniF. 2008. Hypothyroidism and endothelial function: a marker of early atherosclerosis?Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 2:79–96.
3.
BaxterJD, WebbP. 2009. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov, 8:308–320.
4.
BiondiB, CooperDS. 2008. The clinical significance of subclinical thyroid dysfunction. Endocr Rev, 29:76–131.
5.
MonzaniF, DardanoA, CaraccioN. 2006. Does treating subclinical hypothyroidism improve markers of cardiovascular risk?Treat Endocrinol, 5:65–81.
6.
LindemanRD, SchadeDS, LaRueA, RomeroLJ, LiangHC, BaumgartnerRN, KoehlerKM, GarryPJ. 1999. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc, 47:703–709.
7.
NessGC, LopezD, ChambersCM, NewsomeWP, CorneliusP, LongCA, HarwoodHJJr. 1998. Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression. Biochem Pharmacol, 56:121–129.
8.
DuntasLH. 2002. Thyroid disease and lipids. Thyroid, 12:287–293.
CarnarisGJ, ManowitzNR, MayorG, RidgwayEC. 2000. The Colorado thyroid disease prevalence study. Arch Int Med, 160:526–534.
11.
PearceEN. 2004. Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr Cardiol Rep, 6:451–456.
12.
FengX, JiangY, MeltzerP, YenPM. 2000. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol, 14:947–955.
13.
WalshJP, BremnerAP, BulsaraMK, O'LearyP, LeedmanPJ, FeddemaP, MichelangeliV. 2005. Thyroid dysfunction and serum lipids: a community-based study. Clin Endocrinol, 63:670–675.
14.
KvetnyJ, HeldgaardPE, BladbjergEM, GramJ. 2004. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol, 61:232–238.
15.
TanaciN, ErtugrulDT, SahinM, OlcayI, DemiragNG, GursoyA. 2006. Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism. Endocrine, 29:451–456.
16.
OweckiM, NikischE, SowińskiJ. 2006. Hypothyroidism has no impact on insulin sensitivity assessed with HOMA-IR in totally thyroidectomized patients. Acta Clin Belg, 61:69–73.
17.
HandisuryaA, PaciniG, TuraA, GesslA, Kautzky-WillerA. 2008. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH)Clin Endocrinol, 69:963–969.
18.
TuzcuA, BahceciM, GokalpD, TuzunY, GunesK. 2005. Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J, 52:89–94.
19.
GjeddeS, GormsenLC, RungbyJ, NielsenS, JorgensenJOL, PedersenSB, RiisAL, WeekeJ, MollerN. 2010. Decreased lipid intermediate levels and lipid oxidation rates despite normal lipolysis in patients with hypothyroidism. Thyroid, 20:843–849.
20.
FerranniniE, GroopLC. 1989. Hepatic glucose production in insulin-resistant states. Diabetes Metab Rev, 5:711–726.
21.
Yehuda-ShnaidmanE, KalderonB, Bar-TanaJ. 2005. Modulation of mitochondrial transition pore components by thyroid hormone. Endocrinology, 146:2462–2472.
22.
de LangeP, FeolaA, RagniM, SeneseR, MorenoM, LombardiA, SilvestriE, AmatR, VillarroyaF, GogliaF, LanniA. 2007. Differential 3,5,3′-triiodothyronine-mediated regulation of uncoupling protein 3 transcription: role of fatty acids. Endocrinology, 148:4064–4072.
23.
CaraccioN, NataliA, SironiA, BaldiS, FrascerraS, DardanoA, MonzaniF, FerranniniE. 2005. Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine. J Clin Endocrinol Metab, 90:4057–62.
24.
BizeauME, ShortC, ThresherJS, CommerfordSR, WillisWT, PagliassottiMJ. 2001. Increased pyruvate flux capacities account for diet-induced increases in gluconeogenesis in vitro. Am J Physiol Regul Integr Comp Physiol, 281:R427–433.
25.
KernPA, RanganathanG, YukhtA, OngJM, DavisRC. 1996. Translational regulation of lipoprotein lipase by thyroid hormone is via a cytoplasmic repressor that interacts with the 3′ untranslated region. J Lipid Res, 37:2332–2340.
26.
BilezikianJP, LoebJN. 1983. The influence of hyperthyroidism and hypothyroidism on α- and β-adrenergic receptors systems and adrenergic responsiveness. Endocr Rev, 4:378–388.
27.
BlennemannB, MoonYK, FreakeHC. 1992. Tissue-specific regulation of fatty acid synthesis by thyroid hormone. Endocrinology, 130:637–643.
28.
FreakeHC, OppenheimerJH. 1995. Thermogenesis and thyroid function. Annu Rev Nutr, 15:263–291.
29.
ValdemarssonS, HanssonP, HednerP, Nilsson-EhleP. 1983. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations. Acta Endocrinol, 104:50–56.
30.
ValdemarssonS, Nilsson-EhleP. 1987. Hepatic lipase and the clearing reaction: studies in euthyroid and hypothyroid subjects. Horm Metab Res, 19:28–30.
